Changes

6 bytes removed ,  02:16, 1 August 2021
no edit summary
Line 14: Line 14:  
|Christine Bryke || MD || Beth Israel Deaconess Medical Center; CGC Myeloid workgroup || Boston, MA USA
 
|Christine Bryke || MD || Beth Israel Deaconess Medical Center; CGC Myeloid workgroup || Boston, MA USA
 
|-
 
|-
|Fabiola Quintero-Rivera || MD PhD || University of California; CGC Myeloid workgroup || Los Angeles, CA
+
|Fabiola Quintero-Rivera || MD || University of California Irvine; CGC Myeloid workgroup || Los Angeles, CA
 
|-
 
|-
 
|Fei Yang || MD MS || Oregon Health & Science University; CCGA Workgroup || Portland, OR USA
 
|Fei Yang || MD MS || Oregon Health & Science University; CCGA Workgroup || Portland, OR USA
Line 24: Line 24:  
|Jane Houldsworth || PhD || Cancer Genetics, Inc || Franklin Lakes, NJ USA
 
|Jane Houldsworth || PhD || Cancer Genetics, Inc || Franklin Lakes, NJ USA
 
|-
 
|-
|Jennelle Hodges || PhD FACMG || Cedars-Sinai Medical Center || Los Angeles, CA USA
+
|Jennelle Hodge || PhD FACMG || Indiana University || Indianapolis, IN USA
 
|-
 
|-
 
|Linda Baughn || PhD || Mayo Clinic, CCGA Workgroup || Rochester, MN USA
 
|Linda Baughn || PhD || Mayo Clinic, CCGA Workgroup || Rochester, MN USA